The recent instability in global supply have highlighted the necessity of securing essential medications like Ivermectin. Trusting on overseas manufacturers exposes nations to significant vulnerabilities, including transportation delays, cost fluctuations, and even geopolitical threats. Shifting towards domestic procurement of Ivermectin offers a m